Form 4: Verizon Executive Kyle Malady Sells Shares
SEC Form 4 Filing
EVP and Group CEO of Verizon Business, Kyle Malady, sold 6,590 shares of Verizon Communications Inc. common stock at $39.7 per share on February 4, 2025.
Summary
- On February 4, 2025, Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications Inc., sold 6,590 shares of common stock at a price of $39.7 per share.
- Following the transaction, Malady directly owns 0 shares of common stock.
- Malady indirectly owns 18,415 shares through a 401(k).
Sentiment
Score: 5
Explanation: The document is a standard SEC filing for a stock sale, which is a neutral event. The sentiment is neither positive nor negative.
Industry Context
Executive stock sales are a common occurrence and are often scrutinized by investors for insights into a company's prospects, although they don't always indicate a negative outlook.
Stakeholder Impact
- The sale of shares by a high-ranking executive could be perceived negatively by shareholders, potentially leading to a slight decrease in stock value, although this is not always the case.
Key Dates
| Date | Description |
|---|---|
| 02/04/2025 | Date of stock sale transaction. |
| 02/06/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Verizon, Stock Sale, Executive, Kyle Malady, VZ
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.